APA (7th ed.) Citation

Setayeshgar, S., Kingwell, E., Zhu, F., Zhang, X., Zhang, T., Marrie, R. A., . . . Tremlett, H. (2018). Use of the new oral disease-modifying therapies for multiple sclerosis in British Columbia, Canada: The first five-years. Multiple sclerosis and related disorders, 25, 57-60. https://doi.org/10.1016/j.msard.2018.07.012

Chicago Style (17th ed.) Citation

Setayeshgar, Solmaz, Elaine Kingwell, Feng Zhu, Xinyu Zhang, Tingting Zhang, Ruth Ann Marrie, Robert Carruthers, and Helen Tremlett. "Use of the New Oral Disease-modifying Therapies for Multiple Sclerosis in British Columbia, Canada: The First Five-years." Multiple Sclerosis and Related Disorders 25 (2018): 57-60. https://doi.org/10.1016/j.msard.2018.07.012.

MLA (9th ed.) Citation

Setayeshgar, Solmaz, et al. "Use of the New Oral Disease-modifying Therapies for Multiple Sclerosis in British Columbia, Canada: The First Five-years." Multiple Sclerosis and Related Disorders, vol. 25, 2018, pp. 57-60, https://doi.org/10.1016/j.msard.2018.07.012.